Lots of interesting abstracts and cases were submitted for TCTAP 2023. Below are the accepted ones after a thorough review by our official reviewers. Don’t miss the opportunity to expand your knowledge and interact with authors as well as virtual participants by sharing your opinion in the comment section!
TCTAP A-018
Acute STEMI : Before and During the COVID-19 Pandemic Single Center Study
By Fazila Malik, Md Kalimuddin, Shamim Chowdhury, Nazir Ahmed, Mohammad Badiuzzaman, Mir Nesaruddin Ahmed, Ashok Kumar Dutta, Dhiman Banik, Habibur Rahman, Tawfiq Shahriar Huq
Presenter
Shamim Chowdhury
Authors
Fazila Malik1, Md Kalimuddin1, Shamim Chowdhury1, Nazir Ahmed1, Mohammad Badiuzzaman1, Mir Nesaruddin Ahmed1, Ashok Kumar Dutta1, Dhiman Banik1, Habibur Rahman1, Tawfiq Shahriar Huq1
Affiliation
National Heart Foundation Hospital & Research Institute, Bangladesh1
View Study Report
TCTAP A-018
Acute Coronary Syndromes (STEMI, NSTE-ACS)
Acute STEMI : Before and During the COVID-19 Pandemic Single Center Study
Fazila Malik1, Md Kalimuddin1, Shamim Chowdhury1, Nazir Ahmed1, Mohammad Badiuzzaman1, Mir Nesaruddin Ahmed1, Ashok Kumar Dutta1, Dhiman Banik1, Habibur Rahman1, Tawfiq Shahriar Huq1
National Heart Foundation Hospital & Research Institute, Bangladesh1
Background
During COVID-19 pandemic, the pattern of hospital admissions for acute ST-elevation myocardial infarction (STEMI) has been changing, and increased mortality and morbidity is being noted in these patients.Patient may present with acute myocardial infarction, myocarditis simulating a presentation like STEMI, coronary spasm, myocardial injury not fulfilling the criteria of type 1 & type 2 acute MI and cardiomyopathy.In this study we have tried to determine some important differences among the patients presented presented with STEMI during The COVID-19 pandemic versus non-COVID-19 era.
Methods
This prospective observational study was carried out in National Heart Foundation Hospital & Research Institute from 8thMarch,2019 to 7th March, 2021. Total 2531 patients were included. The study populations were divided into two groups. Group I: Acute STEMI patients presenting during pre COVID period (n=1385). Group II: Acute STEMI patients presenting during COVID period (n=1146). COVID period was calculated from 8th march ,2020 onward as first case of COVID -19 was detected on that day in Bangladesh. . All patients presented with Acute STEMI was included in the study however NSTEMI-ACS, Unstable angina were excluded from the study.
Results
Male was predominant in both groups. Regarding risk factors Hypertension, Obesity and family H/O of CAD was statistically significant (p<0.05). Acute STEMI patients presented lately during COVID-19 period probably due to lock down& lack of transport facility. Regarding coronary artery disease severity, vessel score was more during COVID period. SV-CAD were more during pre COVID period while DV-CAD & TV-CAD were more during COVID period. Gensini score was also calculated among the study populations, it was 57.21±28.42 and 63.16± 40.43respectively in group I and group I, which was statistically significant. Regarding treatment options of the patients,primary PCI was less during COVID period, however medical management, elective PCI and Thrombolysis were more during COVID era. Regarding in hospital outcome ,acute LVF, cardiogenic shock were more during COVID period which
were also statistically significant.
Conclusion
During COVID -19, STEMI patients presented lately in comparison to pre COVID period. Coronary artery Disease were more severe during COVID period as evaluated by Vessel Score & Gensini Score. During COVID -19 period majority of patients got medical management& routine PCI were done more in comparison to primary PCI. In Hospital outcome of STEMI was worse during COVID-19 period in terms of acute LVF & cardiogenic shock .
